153 related articles for article (PubMed ID: 10641451)
1. Pharmacologic treatment of type 2 diabetes mellitus: realities and perspectives.
Abdallah MP; Hirbli K
J Med Liban; 1999; 47(4):233-7. PubMed ID: 10641451
[No Abstract] [Full Text] [Related]
2. [Oral antidiabetic drugs--1. For each patient the proper drug].
Bachmann W
MMW Fortschr Med; 2000 Mar; 142(9):41-4. PubMed ID: 10795481
[No Abstract] [Full Text] [Related]
3. Intensive therapy of type 2 diabetes (ACCORD trial) (OCTOBER 2008).
Najman DM
Cleve Clin J Med; 2009 Feb; 76(2):83; author reply 83-4. PubMed ID: 19188472
[No Abstract] [Full Text] [Related]
4. Clinical perspectives in type 2 diabetes care: optimizing glycemic control with insulin therapy.
Diabetes Educ; 2005; Suppl():1-14; quiz 15-6. PubMed ID: 15786628
[No Abstract] [Full Text] [Related]
5. [New, expensive antidiabetics for the treatment of type-2 diabetes--pro].
Müller-Wieland D
Dtsch Med Wochenschr; 2010 May; 135(18):922. PubMed ID: 20425678
[No Abstract] [Full Text] [Related]
6. [Type 2 diabetes: explosive issues in routine care].
Aumiller J
MMW Fortschr Med; 2009 Oct; 151(42):20. PubMed ID: 19938775
[No Abstract] [Full Text] [Related]
7. [Therapeutic strategies in type 2 diabetes].
Waeber G; Vollenweider P; Ruiz J
Praxis (Bern 1994); 2001 Dec; 90(51-52):2245-54. PubMed ID: 11820166
[TBL] [Abstract][Full Text] [Related]
8. [National practice guideline therapy of type 2 diabetes].
Landgraf R;
MMW Fortschr Med; 2014 Mar; 156 Spec No 1(1):76-8. PubMed ID: 24930352
[No Abstract] [Full Text] [Related]
9. [Oral drugs for diabetes--update of current use and availability].
Niskanen L
Duodecim; 2004; 120(8):983-90. PubMed ID: 15185512
[No Abstract] [Full Text] [Related]
10. [Oral antidiabetic agents for the general practitioner].
Siegmund T
MMW Fortschr Med; 2009 Apr; 151(14):86, 88-91; quiz 92. PubMed ID: 19504847
[No Abstract] [Full Text] [Related]
11. [Drug therapy of type 2 diabetes with 1.26g/l fasting blood glucose (see above)].
Slama G; Selam JL; Elgrably F; Reach G
Diabetes Metab; 1999 Nov; 25(5):436-40. PubMed ID: 10592869
[No Abstract] [Full Text] [Related]
12. The ACCORD Trial and control of blood glucose level in type 2 diabetes mellitus: time to challenge conventional wisdom.
Havas S
Arch Intern Med; 2009 Jan; 169(2):150-4. PubMed ID: 19171811
[No Abstract] [Full Text] [Related]
13. [Even if fasting blood glucose value is quite normal, proceed with a glucose tolerance test].
MMW Fortschr Med; 2002 May; 144(20):65. PubMed ID: 12125660
[No Abstract] [Full Text] [Related]
14. Changing the diabetes treatment paradigm.
Hirsch R
Arch Intern Med; 2009 Jul; 169(13):1246; author reply 1247. PubMed ID: 19597080
[No Abstract] [Full Text] [Related]
15. 2008 resource guide. Type 2 drugs. There are now six classes of diabetes pills and several combination oral meds. Each has a different way of helping you control your diabetes.
McCarren M
Diabetes Forecast; 2008 Jan; 61(1):RG7-9. PubMed ID: 18290287
[No Abstract] [Full Text] [Related]
16. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].
Laakso M
Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996
[No Abstract] [Full Text] [Related]
17. [Role of acarbose in the treatment of diabetes mellitus].
Scheen AJ
Diabetes Metab; 1998 Sep; 24(4):385-90. PubMed ID: 9805654
[No Abstract] [Full Text] [Related]
18. [Oral therapy in type 2 diabetes. Critical evaluation of glitazones].
Lotz N
MMW Fortschr Med; 2002 Jan; 144(3-4):48-50. PubMed ID: 11862793
[No Abstract] [Full Text] [Related]
19. A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.
Ross SA; Zinman B; Campos RV; Strack T;
Clin Invest Med; 2001 Dec; 24(6):292-8. PubMed ID: 11767232
[TBL] [Abstract][Full Text] [Related]
20. Oral medicines for type 2 diabetes.
Geil P; Hieronymus L
Diabetes Self Manag; 2005; 22(4):6, 8-10, 12. PubMed ID: 16121426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
